Test Price
2,800 AED✅ Home Collection Available
RAD51C Gene Mutation Analysis (Hereditary Breast & Ovarian Cancer) – Next‑Generation Sequencing in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee
- 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM.
- Clinical Guidance
- Telephonic Post-Test Clinical Guidance for Result Interpretation – discuss findings with DHA-licensed genetic counsellors and medical geneticists.
- Insurance
- Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
RAD51C Gene Mutation Analysis is a clinically validated Next‑Generation Sequencing (NGS) test that detects germline mutations in the RAD51C gene, a key player in hereditary breast and ovarian cancer syndrome. This 2,800 AED investigation empowers high‑risk individuals and their physicians to make proactive, personalised screening and prevention decisions.
| Feature | RAD51C UAE Power Test | Standard Local Genetic Panel |
|---|---|---|
| Precision | 99.9% Sensitivity – full‑gene sequencing with CNV detection (NGS + MLPA backup) | Often limited to hotspot analysis; may miss large deletions |
| Methodology | Illumina‑based NGS, ACMG 2026 variant interpretation, Sanger confirmation | Older PCR‑based genotyping or basic Sanger sequencing |
| Turnaround & Support | 3–4 Weeks · Home Collection 8 AM–11 PM · Post‑test tele‑guidance | Often ≥6 Weeks · In‑clinic draw only · Minimal post‑test follow‑up |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (DHA Licence: 9294403) – “As a Consultant Medical Genetics, I emphasise that RAD51C results must always be interpreted alongside full family history and in the context of proper pre‑test counselling. A positive variant does not alone dictate your cancer fate, but it empowers you and your care team to implement life‑saving surveillance or prophylactic measures. Always discuss your results with a qualified genetic counsellor before making any medical decision.”
Medication & Lifestyle Advisory
Do not discontinue prescribed medication (e.g., oral contraceptives, hormonal therapies) or modify screening schedules without consulting your managing physician. This genetic test provides risk information, not a clinical diagnosis, and must be integrated with ongoing specialist care.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria: Individuals under 18 without court‑appointed legal guardian consent; inability to give informed consent (e.g., acute psychiatric crisis); sample contamination or insufficient DNA yield.
Red Flags – Seek Emergency Help if you experience: severe anxiety, panic attacks, or suicidal ideation after receiving results. In such a case, contact emergency services immediately or call our urgent genetic counselling line at +971 54 548 8731.
Patient FAQ & Clinical Guidance
1. What is the RAD51C gene test and why is it important?
This NGS test detects inherited mutations in RAD51C that confer a 20‑40% lifetime ovarian and elevated breast cancer risk, enabling tailored prevention. Pre‑test genetic counselling and pedigree analysis are mandatory to contextualise results.
2. How accurate is the test and what is the turnaround time?
The assay achieves 99.9% analytical sensitivity using NGS with Sanger validation; final results are issued in 3–4 weeks. DNA can be extracted from peripheral whole blood, FTA card, or extracted DNA.
3. Do I need a doctor’s referral or genetic counselling?
Pre‑test genetic counselling is mandatory per UAE Federal Decree‑Law No. 4 of 2016 on Medical Liability to ensure informed consent and proper risk assessment. A detailed family pedigree will be drawn during the counselling session; you can then proceed with the blood draw via home collection or at our facility.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, anonymised for research, and accessible only to licensed healthcare professionals. Clinical safety and patient consent adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | RAD51C Gene Mutation Analysis (Hereditary Breast & Ovarian Cancer) – Next‑Generation Sequencing |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (also accepts FTA card or extracted DNA) |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | Z15.01, Z15.02, Z14.01 |
| LOINC Code | 94755-5 |
| DHA Facility License & Address | License No. 1143 · Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE · DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians